See more : Centrepoint Alliance Limited (CAF.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Neptune Wellness Solutions Inc. (NEPT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Neptune Wellness Solutions Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Thomson Resources Ltd (TMZRF) Income Statement Analysis – Financial Results
- paragon GmbH & Co. KGaA (0NFG.L) Income Statement Analysis – Financial Results
- Northern Star Investment Corp. IV (NSTD-UN) Income Statement Analysis – Financial Results
- Takase Corporation (9087.T) Income Statement Analysis – Financial Results
- 3D Systems Corporation (0QYH.L) Income Statement Analysis – Financial Results
Neptune Wellness Solutions Inc. (NEPT)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.neptunewellness.com
About Neptune Wellness Solutions Inc.
Neptune Wellness Solutions Inc. operates as an integrated health and wellness company in Canada, the United States, and internationally. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, MaxSimil, and NurturMe brands. The company also offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, including nutraceuticals, beauty and personal care products, and organic foods and beverages. In addition, it is involved in the extraction, purification, formulation, and manufacturing of health and wellness products. Further, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 52.62M | 61.01M | 44.49M | 29.58M | 24.44M | 27.65M | 43.22M | 22.63M | 15.07M | 19.50M | 25.95M | 19.25M | 17.06M | 12.05M | 10.32M | 7.60M | 6.28M | 4.01M | 1.66M | 1.66M | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 74.45M | 71.58M | 80.07M | 31.42M | 16.83M | 21.32M | 31.40M | 18.06M | 23.09M | 16.97M | 15.63M | 9.12M | 14.21M | 10.61M | 8.91M | 5.88M | 5.90M | 3.62M | 2.71M | 2.71M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -21.84M | -10.58M | -35.58M | -1.84M | 7.61M | 6.32M | 11.82M | 4.57M | -8.02M | 2.52M | 10.31M | 10.13M | 2.85M | 1.43M | 1.41M | 1.72M | 382.33K | 398.16K | -1.05M | -1.05M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | -41.51% | -17.34% | -79.96% | -6.22% | 31.15% | 22.88% | 27.34% | 20.18% | -53.20% | 12.93% | 39.75% | 52.64% | 16.68% | 11.91% | 13.69% | 22.57% | 6.09% | 9.92% | -62.95% | -62.95% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 484.22K | 1.10M | 2.43M | 2.94M | 7.29M | 15.30M | 6.69M | 7.14M | 9.98M | 8.53M | 8.18M | 3.93M | 2.59M | 2.61M | 487.30K | 362.29K | 338.33K | 155.71K | 175.82K | 597.55K | 647.78K | 419.88K | 103.26K | 103.26K |
| General & Administrative | 0.00 | 0.00 | 89.34M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.60M | 26.52M | 15.32M | 9.86M | 736.02K | 461.05K | 2.17M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 357.74K | 18.06K | 18.06K |
| Selling & Marketing | 0.00 | 0.00 | -19.47M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.45M | 2.24M | 2.41M | 2.10M | 0.00 | 0.00 | 2.35M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.83K | 11.83K | 0.00 |
| SG&A | 46.42M | 75.81M | 81.62M | 62.16M | 15.29M | 15.30M | 15.75M | 13.75M | 23.63M | 32.00M | 18.15M | 11.96M | 736.02K | 461.05K | 4.52M | 2.65M | 2.65M | 0.00 | 0.00 | 1.17M | 1.01M | 369.57K | 18.06K | 18.06K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.25M | 730.97K | 1.05M | 599.87K | 532.19K | 944.48K | 777.08K | 707.85K | 33.57K | 23.79K | 5.77K | 0.00 |
| Operating Expenses | 46.91M | -92.30M | -122.78M | -53.99M | -30.42M | 2.48M | -6.34M | -15.99M | -20.84M | -24.77M | -29.26M | 15.90M | 4.57M | 3.80M | 5.61M | 3.54M | 1.28M | 932.80K | 883.67K | 1.80M | 1.68M | 795.22K | 121.32K | 121.32K |
| Cost & Expenses | 102.00M | -20.71M | -42.71M | -22.57M | -13.59M | 23.81M | 25.06M | 2.08M | 2.25M | -7.80M | -13.63M | 25.01M | 18.79M | 14.42M | 14.51M | 9.42M | 7.18M | 4.55M | 3.59M | 1.80M | 1.68M | 795.22K | 121.32K | 121.32K |
| Interest Income | 1.45K | 7.12K | 38.33K | 106.63K | 184.73K | 176.14K | 0.00 | 78.47K | 122.76K | 12.82K | 145.69K | 124.58K | 22.88K | 43.27K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 30.08K | 30.08K | 0.00 |
| Interest Expense | 2.20M | 1.54M | 916.09K | 411.58K | 340.87K | 1.04M | -2.49M | 1.07M | 696.38K | 0.00 | 156.56K | 381.81K | 397.89K | 645.42K | 1.07M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 30.08K | 0.00 |
| Depreciation & Amortization | 3.69M | 7.60M | 23.96M | 7.93M | 3.05M | 3.54M | 3.52M | 2.58M | 1.72M | 352.94K | 613.20K | 768.41K | 943.32K | 730.97K | 599.87K | 532.19K | 966.03K | 797.10K | 724.96K | 39.90K | 23.79K | -5.77K | -5.77K | 0.00 |
| EBITDA | -63.05M | -79.89M | -95.65M | -58.94M | -11.84M | -18.99M | -4.88M | -13.19M | -39.51M | -37.27M | -14.86M | -4.87M | -3.41M | -1.59M | -3.34M | -1.11M | -950.60K | 324.37K | -1.20M | -1.76M | -1.66M | -789.45K | -121.32K | -121.32K |
| EBITDA Ratio | -119.84% | -130.95% | -214.99% | -199.28% | -48.43% | -68.69% | -11.28% | -58.27% | -262.19% | -191.16% | -57.26% | -25.30% | -20.01% | -13.22% | -32.39% | -14.59% | -15.14% | 8.08% | -72.51% | -106.11% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -66.74M | -87.49M | -119.61M | -66.87M | -14.88M | -22.53M | -8.40M | -15.77M | -41.23M | -37.62M | -15.47M | -5.76M | -1.87M | -3.01M | -4.19M | -1.83M | -900.48K | -534.64K | -1.93M | -1.80M | -1.68M | -795.22K | -121.32K | -121.32K |
| Operating Income Ratio | -126.85% | -143.41% | -268.84% | -226.08% | -60.89% | -81.50% | -19.44% | -69.67% | -273.60% | -192.97% | -59.63% | -29.94% | -10.96% | -25.01% | -40.61% | -24.02% | -14.34% | -13.32% | -116.18% | -108.51% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -53.28M | -17.02M | -40.94M | 10.61M | -8.14M | 30.23M | 11.38M | 3.01M | 11.65M | 15.38M | -3.49M | 138.13K | 2.63M | 1.55M | 2.30M | -184.53K | 1.94M | -61.91K | -1.46M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -120.02M | -105.55M | -160.55M | -56.26M | -23.02M | 7.70M | 2.98M | -12.76M | -29.58M | -22.24M | -18.96M | -5.63M | 760.09K | -1.46M | -1.89M | -2.01M | 115.69K | -596.54K | -1.99M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | -228.11% | -173.01% | -360.85% | -190.22% | -94.19% | 27.85% | 6.91% | -56.37% | -196.27% | -114.06% | -73.08% | -29.22% | 4.46% | -12.12% | -18.31% | -26.45% | 1.84% | -14.86% | -119.90% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -38.31M | -11.82M | 4.37M | 4.60M | 170.01K | 1.64M | 2.17M | 1.93M | 245.09K | 0.00 | 1.00M | -1.01M | -2.25M | 645.42K | 620.39K | 678.09K | -95.65K | 873.96K | 603.31K | 628.25K | -12.48K | -18.54K | 5.77K | 121.32K |
| Net Income | -81.71M | -93.73M | -154.80M | -60.86M | -23.19M | 17.53M | 6.38M | -7.47M | -27.96M | -16.64M | -16.77M | -4.62M | 527.52K | -1.46M | -4.81M | -2.50M | -804.82K | -1.41M | -2.59M | -2.43M | -1.67M | -765.13K | -121.32K | -121.32K |
| Net Income Ratio | -155.30% | -153.64% | -347.93% | -205.77% | -94.88% | 63.41% | 14.77% | -33.01% | -185.54% | -85.35% | -64.64% | -24.00% | 3.09% | -12.12% | -46.62% | -32.95% | -12.82% | -35.08% | -156.24% | -146.35% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -276.70 | -777.15 | -1.79K | -947.05 | -408.20 | 309.27 | 114.62 | -138.09 | -525.08 | -383.03 | -434.22 | -3.35 | -0.36 | -1.35 | -4.54 | -2.47 | -0.91 | -1.94 | -4.15 | -5.43 | -3.95 | -2.65 | -0.60 | -0.60 |
| EPS Diluted | -276.70 | -777.15 | -1.79K | -947.05 | -408.20 | 309.27 | 114.62 | -140.00 | -525.08 | -383.03 | -434.22 | -3.35 | -0.36 | -1.35 | -4.54 | -2.47 | -0.91 | -1.94 | -4.15 | -5.43 | -3.95 | -2.65 | -0.60 | -0.60 |
| Weighted Avg Shares Out | 295.31K | 120.61K | 86.54K | 64.27K | 56.81K | 56.14K | 55.68K | 53.36K | 53.25K | 43.44K | 38.62K | 1.38M | 1.16M | 1.08M | 1.06M | 1.01M | 879.74K | 727.23K | 625.29K | 447.34K | 421.95K | 288.57K | 201.14K | 201.14K |
| Weighted Avg Shares Out (Dil) | 295.31K | 120.61K | 86.63K | 64.27K | 56.81K | 56.69K | 55.82K | 54.10K | 53.25K | 43.44K | 38.62K | 1.38M | 1.16M | 1.08M | 1.06M | 1.01M | 879.74K | 727.23K | 625.29K | 447.34K | 421.95K | 288.57K | 201.14K | 201.14K |
2 Marijuana Stocks That Could Be The Ones You Want?
2 Canadian Marijuana Stocks For Your 2022 Watchlist The post 2 Marijuana Stocks That Could Be The Ones You Want? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Popular Penny Stocks For Your Buy List Today? 3 to Watch
Here's what you need to know about trading penny stocks on August 24th The post Popular Penny Stocks For Your Buy List Today? 3 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Best Penny Stocks To Buy Now? 4 To Watch As APE Stock Goes Public
Hot penny stocks to watch but are they a buy now or not? Let's look at the catalysts.
Top Marijuana Stocks To Watch Before Next Week
Are Penny Pot Stocks Rallying In August? The post Top Marijuana Stocks To Watch Before Next Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Penny Stocks To Watch: Why EDBL AGRI & NEPT Stocks Exploded This Week
Hot penny stocks to watch today. The post Penny Stocks To Watch: Why EDBL AGRI & NEPT Stocks Exploded This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Neptune Wellness Solutions Inc. (NEPT) CEO Michael Cammarata on Q1 2023 Results - Earnings Call Transcript
Neptune Wellness Solutions Inc. (NASDAQ:NEPT ) Q1 2023 Results Conference Call August 15, 2022 5:00 PM ET Company Participants Morry Brown - Vice President, Investor Relations Michael Cammarata - President and Chief Executive Officer Raymond Silcock - Chief Financial Officer...
Neptune Reports Fiscal First Quarter 2023 Financial Results
Fiscal Q1 2023 revenue totaled $16.3 million, an increase of 61% year-over-year Sprout recorded $8.2 million in revenue, its largest net sales quarter on record Personal Care and Beauty recorded $5.1 million in revenue, the highest in over two years...
Neptune to Report Fiscal First Quarter 2023 Financial Results on August 15, 2022
Management will host a conference call at 5:00 p.m. ET on the same day LAVAL, QC , Aug. 12, 2022 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX: NEPT), a diversified and fully integrated health...
Top Marijuana Stocks Showing Momentum 1st Week Of August
These Top Pot Stocks Are Showing Upside First Week Of August The post Top Marijuana Stocks Showing Momentum 1st Week Of August appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Neptune Wellness Solutions Inc. Announces Voluntary Delisting from Toronto Stock Exchange
LAVAL, QC , July 29, 2022 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX: NEPT), a diversified and fully integrated health and wellness company focused on plant-based, sustainable and purpose-driven lifestyle brands, announced today that...
Source: https://incomestatements.info
Category: Stock Reports